Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

NCT00890253 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Chronic Renal Insufficiency

Interventions

DRUG: Basiliximab (Simulect)
DRUG: Myfortic
DRUG: everolimus
DRUG: Prednisolone

Sponsor

Armin Goralczyk